My Prostate Score 2.0 (MPS2)

Men with an elevated PSA level may want the MPS2 test to better understand their true risk of prostate cancer and determine the next steps in care. Consult with your doctor to determine if MPS2 is right for you.

MPS2 can be ordered by your primary care doctor in their office.

Within 5-7 business days, an MPS2 report will be sent to your doctor, who will discuss the results with you at your next appointment.

MPS2 calculates a personalized risk score for prostate cancer. It’s reported as a percentage and is categorized as “low risk” or “increasing risk” of high-grade prostate cancer. An increased risk score means you may need further intervention such as a prostate biopsy, whereas a low-risk score suggests that a biopsy may be avoidable in favor of a less invasive approach such as ongoing monitoring of lab tests.  See a sample of a MPS2 result report and learn more about how to interpret these results.

Yes, insured patients will not pay for MPS2 or pay only a partial cost, depending on the insurance. You may receive a bill in the mail from Lynx Dx if your insurance does not cover the full cost.

Although there are many factors that contribute to your healthcare provider’s decision to conduct a prostate biopsy, there are several urinary and blood based PCMs that may help guide you and your physician through the decision of conducting a prostate biopsy. These include:

• Select mdx
• 4K
• Prostate health index (phi)
• ExoDx
• MPS2

Genetic tests also may be worth considering if you have a family history of prostate cancer, breast cancer, ovarian cancer or colorectal cancer. These genetic tests are recommended for men who are determined through genetic counseling to be at potential risk for hereditary cancer:

• Myriad myRisk
• ProstateNext
• Ambry Score